Literature DB >> 1303506

Diffuse noxious inhibitory controls (DNIC) in animals and in man.

D Le Bars1, L Villanueva, D Bouhassira, J C Willer.   

Abstract

Some neurones in the dorsal horn of the spinal cord are strongly inhibited when a nociceptive stimulus is applied to any part of the body, distinct from their excitatory receptive fields. This phenomenon was termed "Diffuse Noxious Inhibitory Controls" (DNIC). DNIC influence only convergent neurones: the other cell types which are found in the dorsal horn, including specific nociceptive neurones, are not affected by this type of control. In normal conditions, these inhibitions can be triggered only by conditioning stimuli which are nociceptive. The inhibitions are then extremely potent, affect all the activities of the convergent neurones and persist, sometimes for several minutes, after the removal of the conditioning stimulus. In fact, only activity of A delta- or A delta- and C-peripheral fibres can trigger DNIC. DNIC are sustained by a complex loop which involves supraspinal structures since, unlike segmental inhibitions, they can not be observed in animals in which the cord has previously been transsected at the cervical level. The ascending and descending limbs of this loop travel respectively through the ventro-lateral and dorso-lateral funiculi respectively. We proposed that DNIC result from the physiological activation of some brain structures putatively involved in descending inhibition. However, lesions of the following structures did not modify DNIC: Periaqueductal grey (PAG), Cuneiform nucleus, Parabrachial area, locus coeruleus/subcoeruleus, rostral ventromedial medulla (RVM) including Raphe Magnus, Gigantocellularis and Paragigantocellularis nuclei. By contrast, lesions of Subnucleus Reticularis Dorsalis (SPD) in the caudal medulla strongly reduced DNIC. Both electrophysiological and anatomical data support the involvement of SRD neurones in spin-bulbo-spinal loop(s). Indeed, they are unresponsive to visual, auditory or proprioceptive stimulation but are preferentially or exclusively activated by nociceptive stimuli with a "whole-body receptive field"; they encode precisely the intensity of cutaneous and visceral stimulation within the noxious range and are exclusively activated by cutaneous A delta- or A delta- and C-fibre peripheral volleys; they send descending projections through the dorsolateral funiculus that terminate in the dorsal horn at all levels of the spinal cord. In man, exactly analogous results have been obtained by means of combined psychophysical measurements and recordings of nociceptive reflexes. Electrical stimulation of the sural nerve at the ankle simultaneously induces a nociceptive reflex in a flexor muscle of the knee (the RIII reflex) and a painful sensation from the territory of the nerve. Painful heterotopic conditioning stimuli, no matter whether thermal, mechanical or chemical in nature, depress both the reflex and the associated painful sensation, with stronger effects being observed with more intense conditioning stimuli.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1303506

Source DB:  PubMed          Journal:  Patol Fiziol Eksp Ter        ISSN: 0031-2991


  53 in total

1.  Influence of oral contraceptives on endogenous pain control in healthy women.

Authors:  Taraneh Rezaii; Malin Ernberg
Journal:  Exp Brain Res       Date:  2010-04-24       Impact factor: 1.972

2.  GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.

Authors:  Miriam Kunz; Kirsten Elisabeth Scholl; Ulrich Schu; Stefan Lautenbacher
Journal:  Exp Brain Res       Date:  2006-07-01       Impact factor: 1.972

Review 3.  Understanding fibromyalgia: lessons from the broader pain research community.

Authors:  David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2009-08       Impact factor: 5.820

4.  Transcutaneous electrical nerve stimulation improves fatigue performance of the treated and contralateral knee extensors.

Authors:  D G Behm; E M Colwell; G M J Power; H Ahmadi; A S M Behm; A Bishop; C Murph; J Pike; B McAssey; K Fraser; S Kearley; M Ryan
Journal:  Eur J Appl Physiol       Date:  2019-11-06       Impact factor: 3.078

Review 5.  Alleviating pain with delta opioid receptor agonists: evidence from experimental models.

Authors:  Sophie Berthiaume; Khaled Abdallah; Véronique Blais; Louis Gendron
Journal:  J Neural Transm (Vienna)       Date:  2020-03-18       Impact factor: 3.575

Review 6.  Contribution of Baroreceptor Function to Pain Perception and Perioperative Outcomes.

Authors:  Heberto Suarez-Roca; Rebecca Y Klinger; Mihai V Podgoreanu; Ru-Rong Ji; Martin I Sigurdsson; Nathan Waldron; Joseph P Mathew; William Maixner
Journal:  Anesthesiology       Date:  2019-04       Impact factor: 7.892

7.  Investigation of central pain processing in postoperative shoulder pain and disability.

Authors:  Carolina Valencia; Roger B Fillingim; Mark Bishop; Samuel S Wu; Thomas W Wright; Michael Moser; Kevin Farmer; Steven Z George
Journal:  Clin J Pain       Date:  2014-09       Impact factor: 3.442

8.  Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.

Authors:  Akiko Okada-Ogawa; Frank Porreca; Ian D Meng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 9.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02

10.  Impaired modulation of pain in patients with postherpetic neuralgia.

Authors:  Gisele Pickering; Bruno Pereira; Elodie Dufour; Sylvie Soule; Claude Dubray
Journal:  Pain Res Manag       Date:  2014-01-14       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.